India's Sun Pharma posts higher quarterly profit on strong demand
India's Sun Pharma posts higher quarterly profit on strong demand July 31 (Reuters) - India's Sun Pharmaceutical Industries SUN.NS reported a 27% rise in quarterly profit on Friday, boosted by strong demand for its high-margin specialty medicines used to treat chronic and complex conditions.
Consolidated net profit rose to 28.95 billion rupees ($303.54 million) in the quarter ended June 30 from 22.79 billion rupees a year earlier.
($1 = 95.3750 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru; Editing by Subhranshu Sahu)
((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses